OMEPRAZOLE IN THE TREATMENT OF EROSIVE ESOPHAGITIS REFRACTORY TO HIGH-DOSE CIMETIDINE AND RANITIDINE

被引:64
|
作者
BARDHAN, KD [1 ]
MORRIS, P [1 ]
THOMPSON, M [1 ]
DHANDE, DS [1 ]
HINCHLIFFE, RFC [1 ]
JONES, RB [1 ]
DALY, MJ [1 ]
CARROLL, NJH [1 ]
机构
[1] ASTRA CLIN RES UNIT, EDINBURGH, SCOTLAND
关键词
D O I
10.1136/gut.31.7.745
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Forty five patients with refractory oesophagitis, defined as persisting erosive changes or ulceration despite a minimum of three months' treatment with cimetidine 3.2 g daily or ranitidine 0.9 g daily, were treated in an open trial with omeprazole 40 mg daily for up to eight weeks. Endoscopically defined healing was observed in 73% of patients after four weeks' treatment and in 91% after eight weeks' treatment. Symptoms were completely relieved in 60% of patients, improved in 34%, unchanged in 4%, and worsened in 2%. After healing patients returned to maintenance treatment with cimetidine 1.6-3.2 g daily, depending on the severity of their illness before treatment with omeprazole. By six months and 12 months only 55% and 33% of patients respectively were still in remission. This study suggests that when erosive oesophagitis is refractory to treatment with high dose cimetidine or ranitidine, treatment with omeprazole 40 mg daily for up to eight weeks is effective in inducing healing and relieving symptoms.
引用
下载
收藏
页码:745 / 749
页数:5
相关论文
共 50 条
  • [1] OMEPRAZOLE IN THE TREATMENT OF EROSIVE ESOPHAGITIS (EE) REFRACTORY TO HIGH-DOSE CIMETIDINE
    BARDHAN, KD
    MORRIS, P
    THOMPSON, M
    DHANDE, D
    HINCHLIFFE, RFC
    DALY, MJ
    CAROLL, N
    KRAKOWCZYK, C
    GASTROENTEROLOGY, 1987, 92 (05) : 1306 - 1306
  • [2] VALUE OF OMEPRAZOLE IN THE MANAGEMENT OF EROSIVE ESOPHAGITIS REFRACTORY TO HIGH-DOSE CIMETIDINE
    BARDHAN, KD
    MORRIS, P
    THOMPSON, M
    DHANDE, DS
    HINCHLIFFE, RFC
    DALY, MJ
    CARROLL, NJH
    KRAKOWCZYK, C
    GUT, 1987, 28 (10) : A1375 - A1375
  • [3] OMEPRAZOLE AND HIGH-DOSE RANITIDINE IN THE TREATMENT OF REFRACTORY REFLUX ESOPHAGITIS
    CUCCHIARA, S
    MINELLA, R
    IERVOLINO, C
    FRANCO, MT
    CAMPANOZZI, A
    FRANCESCHI, M
    DARMIENTO, F
    AURICCHIO, S
    ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (06) : 655 - 659
  • [4] REFRACTORY EROSIVE ESOPHAGITIS - RESULTS OF MAINTENANCE TREATMENT WITH HIGH-DOSE H-2-RECEPTOR ANTAGONISTS OR OMEPRAZOLE
    BARDHAN, KD
    DALY, MJ
    SINGH, S
    MORRIS, P
    THOMPSON, M
    HINCHLIFFE, RFC
    GUT, 1990, 31 (05) : A602 - A602
  • [5] OMEPRAZOLE VERSUS RANITIDINE IN EROSIVE ESOPHAGITIS
    ZEITOUN, P
    DEKERANROUE, ND
    ISAL, JP
    LANCET, 1987, 2 (8559): : 621 - 622
  • [6] Ranitidine versus cimetidine in the healing of erosive esophagitis
    McCartyDawson, D
    Sue, SO
    Morrill, B
    Murdock, RH
    CLINICAL THERAPEUTICS, 1996, 18 (06) : 1150 - 1160
  • [7] OMEPRAZOLE TREATMENT OF CHILDREN WITH PEPTIC ESOPHAGITIS REFRACTORY TO RANITIDINE THERAPY
    KARJOO, M
    KANE, R
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (03): : 267 - 271
  • [8] BARRETTS ULCER - RESPONSE TO STANDARD DOSE RANITIDINE, HIGH-DOSE RANITIDINE, AND OMEPRAZOLE
    LEE, FI
    ISAACS, PET
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1988, 83 (09): : 914 - 916
  • [9] OMEPRAZOLE IS SUPERIOR TO RANITIDINE PLUS METOCLOPRAMIDE IN THE SHORT-TERM TREATMENT OF EROSIVE ESOPHAGITIS
    ROBINSON, M
    DECKTOR, DL
    MATON, PN
    SABESIN, S
    ROUFAIL, W
    KOGUT, D
    ROBERTS, W
    MCCULLOUGH, A
    PARDOLL, P
    SACO, L
    RUSTGI, V
    KOVACS, T
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1993, 7 (01) : 67 - 73
  • [10] OMEPRAZOLE OR HIGH-DOSE RANITIDINE IN THE TREATMENT OF PATIENTS WITH REFLUX ESOPHAGITIS NOT RESPONDING TO STANDARD DOSES OF H-2-RECEPTOR ANTAGONISTS
    LUNDELL, L
    BACKMAN, L
    EKSTROM, P
    ENANDER, LH
    FAUSA, O
    LIND, T
    LONROTH, H
    SANDMARK, S
    SANDZEN, B
    UNGE, P
    WESTIN, IH
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1990, 4 (02) : 145 - 155